Zephyrus Biosciences is a biotechnology company providing research tools to enable protein analysis at the single cell level. Capable of measuring proteins in a large number of single cells at once, addressing the burgeoning single-cell analysis market, the scWestern system, enables western blotting on individual cells for the first time. Based on work done in the labs of UC Berkeley, Zephryus has exclusively licensed the technology underpinning its tools. The company's products will have application in research, drug development, and the individualized medical field. Researchers are suning utilize Zephyrusâs products to gain new insights into the biology of cancer, stem cells, neurology, and human disease and development. In March 2016, it was announced that Minneapolis based Bio-Techne (NYSE: TECH) had acquired Zephyrus Biosciences for an undisclosed amount and that the firm will be "rolled up" into Bio-Techne's protein platforms divisio
